Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive crawled time : 08:20 save search
First Results with Erdafitinib-Releasing Intravesical Delivery System (TAR-210) Show Early Evidence of Positive Clinical Activity in Patients with Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations
Published: 2023-10-22 (Crawled : 08:20) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
tar-210 bladder positive cancer system results show growth
Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant
Published: 2023-10-22 (Crawled : 08:20) - globenewswire.com
OLMA | $10.15 1.5% 1.48% 410K
|
Health Technology
| Email alert
Add to watchlist
positive results study phase 2
Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease at the Alzheimer’s Association International Conference (AAIC) 2023
Published: 2023-07-16 (Crawled : 08:20) - globenewswire.com
ABOS | $3.17 0.32% 0.32% 150K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
acu193 conference disease association alzheimer’s positive international pharmaceuticals topline results study
Positive Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks Highlighted at the 2023 HAEi Regional Conference APAC
Published: 2023-03-18 (Crawled : 08:20) - globenewswire.com
PHVS | $21.1 -0.89% -0.9% 34K
|
| Email alert
Add to watchlist
phvs416 conference positive treatment study
Positive Initial Clinical Data from the B-LIEVE Dose-Confirmation Trial for FLT180a in Hemophilia B Presented at the International Society on Thrombosis and Haemostasis Congress
Published: 2022-07-10 (Crawled : 08:20) - globenewswire.com
FRLN | $6.48 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
flt180 trial positive international
pep+ (PEPSICO POSITIVE) TAKES CENTER STAGE AT EXPO 2020 DUBAI OPENING DAY
Published: 2021-10-02 (Crawled : 08:20) - prnewswire.com
PEP | $177.4 3.61% 3.48% 10M
|
Consumer Non-Durables
| Email alert
Add to watchlist
positive
Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Biomarker-Selected Clinical Trial of MM-121 in Patients with Heregulin Positive Non-Small Cell Lung Cancer
Published: 2015-02-19 (Crawled : 08:20) - globenewswire.com
MACK 4 | $14.72 -0.07% -0.07% 110K
|
Health Technology
| Email alert
Add to watchlist
phase 2 lung cancer positive cancer trial mm-120 biomarkers
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.